Metraipolis › archive › dc_9300bd4e71ee

Prognostic factors associated with recurrent COVID-19 and impact of SARS-CoV-2 vaccine on patients with chronic lymphocytic leukemia — Europe PMC PMID:41584572

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41584572
DOI: 10.3389/fonc.2025.1737446
License (as archived): solo-consultazione
Archived: 2026-11-06T23:31:01.545Z
SHA-256 of the archived text: b098b98a2b3f92a5216aa77075d4c5b18ac4be57a6bed1ebba9c81a0a453143d
Stable URL of this page: https://metraipolis.com/documento/dc_9300bd4e71ee

How to cite

Prognostic factors associated with recurrent COVID-19 and impact of SARS-CoV-2 vaccine on patients with chronic lymphocytic leukemia — Europe PMC PMID:41584572 — Europe PMC (en), https://europepmc.org/article/MED/41584572 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9300bd4e71ee (Metraipolis archive dc_9300bd4e71ee, sha256 b098b98a2b3f92a5216aa77075d4c5b18ac4be57a6bed1ebba9c81a0a453143d)

BibTeX

@misc{dc9300bd4e71ee,
  title = {Prognostic factors associated with recurrent COVID-19 and impact of SARS-CoV-2 vaccine on patients with chronic lymphocytic leukemia — Europe PMC PMID:41584572},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41584572},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9300bd4e71ee; sha256 b098b98a2b3f92a5216aa77075d4c5b18ac4be57a6bed1ebba9c81a0a453143d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584572. Agents can read the archived copy with the MCP tool read_document.